Business Description
Diva Laboratories Ltd
SIC : 111
ISIN : TW0004153002
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 85.12 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.09 | |||||
Interest Coverage | 371.51 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 6.1 | |||||
Beneish M-Score | -3.27 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.6 | |||||
3-Year EBITDA Growth Rate | 4.1 | |||||
3-Year EPS without NRI Growth Rate | 25.4 | |||||
3-Year FCF Growth Rate | 23.9 | |||||
3-Year Book Growth Rate | -2.8 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.29 | |||||
9-Day RSI | 62.43 | |||||
14-Day RSI | 58.76 | |||||
6-1 Month Momentum % | 12.08 | |||||
12-1 Month Momentum % | -14.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.34 | |||||
Quick Ratio | 2.75 | |||||
Cash Ratio | 1.93 | |||||
Days Inventory | 177.05 | |||||
Days Sales Outstanding | 135.97 | |||||
Days Payable | 55.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.58 | |||||
Dividend Payout Ratio | 0.73 | |||||
3-Year Dividend Growth Rate | -40.7 | |||||
Forward Dividend Yield % | 2.58 | |||||
5-Year Yield-on-Cost % | 2.58 | |||||
3-Year Average Share Buyback Ratio | 0.8 | |||||
Shareholder Yield % | 2.47 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 28.84 | |||||
Operating Margin % | 10.88 | |||||
Net Margin % | 8.38 | |||||
FCF Margin % | 29.58 | |||||
ROE % | 5.6 | |||||
ROA % | 4.42 | |||||
ROIC % | 11.22 | |||||
ROC (Joel Greenblatt) % | 14.51 | |||||
ROCE % | 6.57 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 42.03 | |||||
PE Ratio without NRI | 28.84 | |||||
Shiller PE Ratio | 115.87 | |||||
Price-to-Owner-Earnings | 14.74 | |||||
PS Ratio | 3.52 | |||||
PB Ratio | 2.35 | |||||
Price-to-Tangible-Book | 2.35 | |||||
Price-to-Free-Cash-Flow | 11.86 | |||||
Price-to-Operating-Cash-Flow | 11.61 | |||||
EV-to-EBIT | 26.61 | |||||
EV-to-EBITDA | 23.89 | |||||
EV-to-Revenue | 2.63 | |||||
EV-to-FCF | 8.71 | |||||
Price-to-Projected-FCF | 1.69 | |||||
Price-to-Median-PS-Value | 1.51 | |||||
Price-to-Graham-Number | 1.51 | |||||
Price-to-Net-Current-Asset-Value | 3.29 | |||||
Price-to-Net-Cash | 8.37 | |||||
Earnings Yield (Greenblatt) % | 3.77 | |||||
FCF Yield % | 8.46 | |||||
Forward Rate of Return (Yacktman) % | 2.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Diva Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 662.575 | ||
EPS (TTM) (NT$) | 0.94 | ||
Beta | -0.28 | ||
Volatility % | 29.38 | ||
14-Day RSI | 58.76 | ||
14-Day ATR (NT$) | 0.590841 | ||
20-Day SMA (NT$) | 38.8425 | ||
12-1 Month Momentum % | -14.11 | ||
52-Week Range (NT$) | 31 - 49.55 | ||
Shares Outstanding (Mil) | 58.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Diva Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Diva Laboratories Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Diva Laboratories Ltd Frequently Asked Questions
What is Diva Laboratories Ltd(ROCO:4153)'s stock price today?
When is next earnings date of Diva Laboratories Ltd(ROCO:4153)?
Does Diva Laboratories Ltd(ROCO:4153) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |